HR-5605 : Still Just a Bill

Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act

This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration program to: (1) increase access of opioid use disorder treatment services for Medicare beneficiaries, (2) improve physical and mental health outcomes for such beneficiaries, and (3) reduce Medicare expenditures.

Opioid use disorder care teams of practitioners may apply for participation in the demonstration project. The CMS must establish a performance-based incentive payment for participating teams.

The CMS must adopt or develop program quality standards and performance methods.

Action Timeline

Action DateTypeTextSource
2018-06-20IntroReferralReceived in the Senate and Read twice and referred to the Committee on Finance.Senate
2018-06-19FloorThe title of the measure was amended. Agreed to without objection.House floor actions
2018-06-19FloorMotion to reconsider laid on the table Agreed to without objection.House floor actions
2018-06-19FloorOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5239-5241)House floor actions
2018-06-19FloorDEBATE - The House proceeded with forty minutes of debate on H.R. 5605.House floor actions
2018-06-19FloorConsidered under suspension of the rules. (consideration: CR H5239-5243)House floor actions
2018-06-19FloorMr. Walden moved to suspend the rules and pass the bill, as amended.House floor actions
2018-06-12CalendarsPlaced on the Union Calendar, Calendar No. 578.House floor actions
2018-06-12DischargeCommittee on Ways and Means discharged.House floor actions
2018-06-12CommitteeReported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-744, Part I.House floor actions
2018-05-17CommitteeOrdered to be Reported (Amended) by Voice Vote.House committee actions
2018-05-17CommitteeCommittee Consideration and Mark-up Session Held.House committee actions
2018-05-01CommitteeReferred to the Subcommittee on Health.House committee actions
2018-04-24IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2018-04-24IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2018-04-24IntroReferralIntroduced in HouseLibrary of Congress

Policy Area :

Health
See Subjects
  • Congressional oversight
  • Drug therapy
  • Drug trafficking and controlled substances
  • Drug, alcohol, tobacco use
  • Government studies and investigations
  • Health care quality
  • Health personnel
  • Health programs administration and funding
  • Home and outpatient care
  • Hospital care
  • Medicare
  • Mental health
  • Performance measurement
  • Prescription drugs
  • User charges and fees

Related Bills

See Related Bills